OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2024
(2)
2021
(2)
2017
(2)
2016
(2)
2025
(1)
2023
(1)
2019
(1)
2001
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America.
Not available
S-EPMC60115
|
biostudies-literature
Cite
Causal Association Between Subtypes of Excessive Daytime Sleepiness and Risk of Cardiovascular Diseases.
Not available
S-EPMC10863774
|
biostudies-literature
Cite
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden.
Not available
S-EPMC8010222
|
biostudies-literature
Cite
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
Not available
S-EPMC5090978
|
biostudies-literature
Cite
Genome-wide association analysis of composite sleep health scores in 413,904 individuals.
Not available
S-EPMC10863010
|
biostudies-literature
Cite
Genome-wide association analysis of composite sleep health scores in 413,904 individuals.
Not available
S-EPMC11760956
|
biostudies-literature
Cite
Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes.
Not available
S-EPMC6692391
|
biostudies-literature
Cite
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288
|
biostudies-literature
Cite
The Society for Cardiovascular Magnetic Resonance Registry at 150,000.
Not available
S-EPMC11314894
|
biostudies-literature
Cite
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.
Not available
S-EPMC5346183
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets